The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Dutasteride (Dutas (0.5 mg)) is a ...

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

The FDA has notified healthcare professionals that the Warnings and Precautions section of the labeling for the class of 5-alpha reductase inhibitors has been revised to include new safety information ...

This was a double-blind, randomized and placebo-controlled trial conducted at six centers in the USA. Two weeks after their screening visit, eligible men were randomized to receive dutasteride, 0.5 mg ...

Please provide your email address to receive an email when new articles are posted on . Daily treatments of dutasteride 0.5 mg were more effective than finasteride 1 mg daily or placebo in increasing ...

GlaxoSmithKline (GSK) announced today that the Swiss regulatory authority, Swissmedic, has granted approval for Duodart®, a fixed dose combination (FDC) of dutasteride (0.5mg) and tamsulosin (0.4mg).

olaparib targets prostate cancer mutations In a study, use of the medication was associated with a significant 61% decreased risk. SAN DIEGO—Dutasteride use is associated with a decreased risk of ...

The purpose of this study was to determine the effect of dutasteride on quality of life of men with lower urinary tract symptoms associated with enlarged prostate or benign prostatic hyperplasia (BPH) ...

Objective: The purpose of this study was to examine the rates of acute urinary retention (AUR) and surgery after initiating 5-alpha reductase inhibitor (5ARI) therapy and to compare the 2 currently ...

The effect of ADT on objective cognitive performance and self-reported cognitive functionin men with prostate cancer. Background: REDUCE was a 4-year, randomized placebo (pbo) controlled study of ...